Quantification of Circulating HPV DNA as a Biomarker for Cervical pre-cancer and cancer: A Pilot Study
ctHPV DNA is a promising biomarker in locally advanced cervical cancer and should be further investigated for clinical use. In ESCC patients, the detection rate of ctHPV DNA is not sufficient for clinical benefit even using ddPCR, the most sensitive technologies available.
Authors
- Esha Jafa
- Madhu Kumar
- Shalini Bhalla (ORCID: https://orcid.org/0000-0002-7802-7129)
- Nisha Singh
- Shivanjali Raghuvanshi (ORCID: https://orcid.org/0000-0002-8382-0818)
- Himanshu Srivastava (ORCID: https://orcid.org/0000-0002-2382-4307)
- Nitu Nigam (ORCID: https://orcid.org/0000-0002-5426-1527)
- Ajay Kumar Singh (ORCID: https://orcid.org/0000-0003-4544-3596)
- A. Gangwar
- Preeti Agarwal
- Sudhir Singh (ORCID: https://orcid.org/0000-0001-5875-2932)
Institutions
- King George's Medical University (IN)
Publication Details
- Journal
- Asian Pacific Journal of Cancer Prevention
- Published
- 2025-05-01
- DOI
- https://doi.org/10.31557/apjcp.2025.26.5.1681
- Citations
- 2
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 2.71